GLUE Sale Disclosure
Bowen Matthew · SEC Form 4 · Filed Oct 6, 2026
Sale
Calculated transaction value
$137.28
Bowen Matthew Principal Accounting Officer
GLUE
Transaction date
Oct 5, 2026
Public filing date
Oct 6, 2026
Filing lag
Filed 1 day later
GLUE daily price context
Close on/before transaction
$10.27
Oct 5, 2026
First close after public filing
$10.17
Oct 7, 2026
Return after filing · so far
-2.9%
Through Oct 13, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 13 shares @ $10.56
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-415540
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$137.28
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Monte Rosa Therapeutics, Inc. GLUE Current | Sale | Oct 5, 2026 | $137.28 |